WHO STAG Working Group on Monitoring Drug Efficacy

The meeting will discuss plans to establish a network of laboratories that can support countries in assessing efficacy of medicines used for the preventive treatment of NTDs. This network will be composed of regional laboratories and their activities will be coordinated by a central laboratory.

The STAG is the principal advisory group to WHO for the control of NTDs and reports directly to the Director-General of WHO. Its mandate is to advise WHO on overall global policies and strategies, ranging from monitoring of implementation to delivery and linkages with other health interventions. Its remit is to facilitate and monitor the coverage of control interventions and to provide WHO with high-quality, well considered advice and recommendations on matters described in its terms of reference.

The STAG can appoint subworking groups on specific work items, such as the group on monitoring drug efficacy, as described in the terms of reference.

Read the STAG Terms of Reference.